David R. LaVance Jr. was voted in as a new member of Hologic's board of directors at the Feb. 25 annual stockholders meeting. LaVance founded and has served as president of Century Capital Associates, an investment banking firm specializing in
David R. LaVance Jr. was voted in as a new member of Hologic's board of directors at the Feb. 25 annual stockholders meeting. LaVance founded and has served as president of Century Capital Associates, an investment banking firm specializing in bioscience. Previously, he was managing director for KPMG Health Ventures, a life sciences consulting practice of the KPMG accounting firm.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
FDA Approves New PSMA PET Agent POSLUMA for Prostate Cancer Imaging
May 30th 2023Reportedly the first FDA-approved PSMA PET agent with proprietary radiohybrid technology, POSLUMA can be utilized for positron emission tomography (PET) scans of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer and suspected metastasis, and those with suspected prostate cancer recurrence based on an elevated serum prostate-specific antigen (PSA) level.
2 Clarke Drive
Cranbury, NJ 08512